Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy

Pharmaceutics(2024)10.3390/pharmaceutics16101263Source: DataRank Database

Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy is a research paper published in Pharmaceutics (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.75)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Uri Galili ORCID

Live enrichment

PubMed:39458595 PMC:PMC11510312 OpenAlex:https://openalex.org/W4402919483

NIH

Grant: CA85868

NIH

Grant: CA122019

NIH

Grant: CA130295

National Institutes of Health

Grant: 5R01CA085868-02

ENHANCING TUMOR VACCINE IMMUNOGENICITY BY ANTIGAL

National Institutes of Health

Grant: 1R01CA122019-01A2

Xenograft-like rejection of tumors in a-gal glycolipids

National Institutes of Health

Grant: 5R21CA130295-03

Intratumoral Injection of a-gal Glycolipids in Stage IV Melanoma: Phase I Trial

FWCI

1.75

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4923/16/10/1263/pdf

publisherhttps://www.mdpi.com/1999-4923/16/10/1263/pdf

journalhttps://doi.org/10.3390/pharmaceutics16101263

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39458595

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11510312

Fields of Study

Xenotransplantation and immune responseImmunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies Research03 medical and health sciences0302 clinical medicine

Keywords

ImmunotherapyAntigenMicelleTumor immunologyMedicineCancer researchImmunologyChemistryImmune systemTumor antigensCancer ImmunotherapyAnti-gal AntibodyΑ-gal EpitopeΑ-gal GlycolipidsApc RecruitmentAgi-134Α-gal TherapyΑ-gal MicellesRS1-441Pharmacy and materia medicaOncology and OncogenicsMedicine and PharmacologyReview

Sustainable Development Goals

SDG 0: Good health and well-being

Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy

FAIR Checklist

Authors (1)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)